ARVINAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.37 USD | +2.44% |
|
-6.77% | -21.36% |
| 04-24 | Arvinas, Inc. Appoints Randy Teel as Chief Business Officer | CI |
| 04-15 | H.C. Wainwright Cuts Price Target on Arvinas to $87 From $90, Maintains Buy Rating | MT |
Chart calendar Arvinas, Inc.
29763d2cfff7ce5265a6.E0AVCEK3JpMNSmwqtFhqY66JeqAkH_YBZTCVllIiXtI.ZxEsUij6TvlpfC8SgAg5AeXIPMNJTsdoI1Td7wp2c59-LHpHJYQV2FsmHw~c842b41bbbe53b7a1dcad94790763bf4
Upcoming events on Arvinas, Inc.
Past events on Arvinas, Inc.
| 16/04/2024 20:00 | Stifel Virtual Targeted Oncology Days Conference |
| 18/03/2024 13:00 | UBS Virtual CNS Day |
| 12/03/2024 | Jefferies Biotech on the Bay Summit |
| 12/03/2024 17:00 | Leerink Partners Global Biopharma Conference |
| 27/02/2024 12:00 | Q4 2023 Earnings Release |
| 07/02/2024 15:30 | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 08/12/2023 18:00 | San Antonio Breast Cancer Symposium - Poster No:PO5-14-11 |
| 07/12/2023 23:30 | San Antonio Breast Cancer Symposium |
| 07/12/2023 18:00 | San Antonio Breast Cancer Symposium - Poster No:PO3-05-08 |
| 06/12/2023 23:00 | San Antonio Breast Cancer Symposium - Poster No:PO2-20-04 |
| 06/12/2023 23:00 | San Antonio Breast Cancer Symposium - Poster No:PO2-20-03 |
| 06/12/2023 18:00 | San Antonio Breast Cancer Symposium - Poster No:PO1-19-12 |
| 06/12/2023 12:30 | Business Update Call |
| 30/11/2023 14:10 | Evercore ISI HealthCONx Conference |
| 28/11/2023 14:00 | Piper Sandler Healthcare Conference |
| 15/11/2023 | Jefferies London Healthcare Conference |
| 14/11/2023 15:20 | Stifel Healthcare Conference |
| 07/11/2023 | Truist Securities Healthcare Conference |
| 07/11/2023 12:00 | Q3 2023 Earnings Release |
| 22/10/2023 14:00 | European Society for Medical Oncology Congress - Investor Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 43,0 40,3 6.55% | 21,8 26,2 -16.76% | 46,7 36,5 27.87% | 131 121 8.77% | 78,5 170 -53.85% | 158 |
|
EBITDA Million USD | Released Forecast Spread | -50,0 -49,7 -0.55% | -122 -114 -6.63% | -191 -15,4 -1137.11% | -257 -252 -1.99% | -397 -284 -39.66% | -401 |
|
EBIT Million USD | Released Forecast Spread | -51,5 -49,5 -4.17% | -125 -114 -9.7% | -195 -143 -37% | -263 -259 -1.72% | -402 -307 -30.97% | -386 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -70,3 -61,9 -13.59% | -119 -97,0 -23.05% | -191 -180 -6.11% | -262 -250 -4.5% | -364 -277 -31.49% | -354 |
|
Net income Million USD | Released Forecast Spread | -70,3 -65,4 -7.46% | -119 -108 -10.4% | -191 -179 -6.97% | -283 -258 -9.59% | -367 -275 -33.43% | -334 |
|
EPS USD | Released Forecast Spread | -2,13 -2,11 -1.08% | -3,02 -2,72 -10.85% | -3,82 -2,73 -39.86% | -5,31 -4,91 -8.22% | -6,62 -5,07 -30.6% | -5,37 |
| Announcement Date | 16/03/20 | 01/03/21 | 28/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 26,3 14,7 79.02% | 24,2 25,5 -5.14% | 31,3 23,7 32.03% | 30,3 34,7 -12.73% | 38,0 35,3 7.58% | 32,5 27,7 17.18% | 54,5 31,0 75.91% | 34,6 40,1 -13.62% | -43,1 49,3 -187.43% | 33,8 | 55,6 | 33,7 | 40,6 | 28,1 |
|
EBITDA Million USD | Released Forecast Spread | -164 -9,84 -1567.14% | -93,6 | -91,5 | -97,1 | -103 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -54,4 -43,4 -25.33% | -60,0 -51,0 -17.61% | -68,3 -58,2 -17.31% | -67,2 -65,2 -3.11% | -75,4 -67,0 -12.5% | -87,7 -83,3 -5.31% | -74,6 -91,1 18.13% | -73,9 -88,3 16.34% | -165 -73,4 -125.08% | -97,7 | -91,0 | -104 | -93,4 | -136 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,0 -42,0 -26.23% | -58,9 -48,2 -22.24% | -66,6 -54,0 -23.23% | -64,0 -58,1 -10.17% | -72,1 -58,7 -22.93% | -81,2 -80,7 -0.57% | -65,6 -88,0 25.43% | -63,9 -81,2 21.29% | -153 -67,3 -127.8% | -88,8 | -77,6 | -93,8 | -100 | -126 |
|
Net income Million USD | Released Forecast Spread | -53,0 -40,3 -31.51% | -63,4 -47,7 -32.96% | -70,0 -57,7 -21.36% | -66,2 -57,1 -15.92% | -82,9 -57,9 -43.18% | -81,9 -81,6 -0.41% | -66,6 -88,7 24.91% | -64,0 -83,1 22.98% | -155 -64,9 -138.53% | -90,7 | -72,2 | -96,5 | -78,3 | -126 |
|
EPS USD | Released Forecast Spread | -1,00 -0,80 -24.24% | -1,20 -0,92 -30.62% | -1,32 -1,06 -24.1% | -1,24 -1,12 -10.57% | -1,56 -1,17 -33.08% | -1,54 -1,55 0.84% | -1,25 -1,65 24.41% | -1,18 -1,57 24.69% | -2,53 -1,15 -119.25% | -1,34 | -0,99 | -1,43 | -1,39 | -1,59 |
| Announcement Date | 28/02/22 | 05/05/22 | 04/08/22 | 08/11/22 | 23/02/23 | 05/05/23 | 08/08/23 | 07/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Arvinas, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARVN Stock
- Calendar Arvinas, Inc.
